Project Grant HT94252410777
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$1.8M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
This federal Project Grant award, valued at $802,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports preclinical gene therapy studies in a mouse model of TSC2 conducted by Baylor College of Medicine in Houston, Texas. The research aims to transform healthcare for military service members and the public through innovative and impactful biomedical research on genetic disorders. The award commenced on May 1,...
This $1,200,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund Baylor College of Medicine to conduct research on precision glycocalyx editing of the metastatic bone microenvironment over a three-year period from September 15, 2023 to September 14, 2026. As a private non-profit university, Baylor College of Medicine has extensive experience managing federal grants and contracts for biomedical...
This $1,496,576.00 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support advanced biomedical research initiatives at Baylor College of Medicine in Houston, TX. The 4-year award, effective September 1, 2025 through August 31, 2029, will fund research on therapies for classical Ehlers-Danlos syndrome, a genetic disorder. As a prominent research university, Baylor College of Medicine has extensive expertise...
This federal Project Grant award of $2,239,998.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Baylor College of Medicine to investigate the progression from ductal carcinoma in situ (DCIS) to invasive basal-like breast cancer driven by the N-RAS gene. The research project aims to advance the understanding of this disease process with the potential to lead to improved diagnostic and treatment approaches. The award...
The U.S. Department of Defense's Defense Health Agency awarded a $1,200,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Baylor College of Medicine in Houston, Texas. The grant, effective April 1, 2025 through March 31, 2028, supports research to eliminate bone metastasis using a bone-targeting E-cadherin antibody nanogel. As a leading research institution, Baylor College of Medicine has extensive experience collaborating with federal agencies on...
The federal Project Grant award of $1,597,224.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program to support the research project "BCL-XL IN BREAST CANCER METASTASIS AND THERAPY" at Baylor College of Medicine in Houston, Texas. The award, with a performance period from August 1, 2024 to July 31, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $739,720 Project Grant to Baylor College of Medicine on June 1, 2024. The grant supports the "Development of Lead Compounds that Promote Telomere Elongation to Prevent and Treat Bone Marrow Failure in the Telomere Biology Disorders" over a 2-year period ending May 31, 2026. This research aims to develop new medical treatments for rare genetic conditions affecting...
The U.S. Defense Health Agency awarded Baylor College of Medicine a $896,645.00 Project Grant on May 15, 2024 under the Military Medical Research and Development program (CFDA 12.420). This grant supports research to investigate thromboinflammation in rheumatoid arthritis, with a performance period from May 2024 to May 2028. As part of this project, Baylor College of Medicine has provided $28,061 in sub-grant funding to the University of Houston System to construct and characterize wild-type and...
This $1,600,000.00 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at Baylor College of Medicine focused on developing new synthetic lethal combination therapies targeting TopBP1 and the arachidonic acid pathway for breast cancer treatment. The three-year award, with an end date of February 28, 2027, will fund basic, translational, and clinical research aimed at advancing scientific understanding and...
The Project Grant award of $440,000.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund research by Baylor College of Medicine on "Biopolymers for Intestinal Healing and Immune Modulation to Treat Inflammatory Bowel Disease." The award period runs from January 15, 2025 to January 14, 2027. This grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and...